"Aventiv Research in Phoenix, Arizona is conveniently located on W. Baseline Road, with easy access to US-60 and AZ-101. Offering a comfortable patient lounge, high security, and a caring staff, Aventiv is a great choice for your medical studies!"

During the past decade, Aventiv Research Inc. conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aventiv Research Inc." #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Goldfinch Bio, Inc." with 2 trials sponsored, "Allena Pharmaceuticals" with 1 trials sponsored, "Anji Pharma" with 1 trials sponsored and "Bavarian Nordic" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aventiv Research Inc." #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator and "Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Aventiv Research Inc." are "Diabetic Nephropathies" (2 trials), "Glomerulosclerosis, Focal Segmental" (2 trials), "Kidney Diseases" (2 trials), "ADPKD" (1 trials) and "Autosomal Dominant Polycystic Kidney" (1 trials). Many other conditions were trialed in "Aventiv Research Inc." in a lesser frequency.

Most popular intervention types in "Aventiv Research Inc." are "Drug" (11 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Empagliflozin" (2 trials), "Acetaminophen" (1 trials), "BI 690517" (1 trials) and "Bardoxolone methyl oral capsule" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aventiv Research Inc." are 15 trials for "All" genders.

Currently, there are NaN active trials in "Aventiv Research Inc.". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Aventiv Research Inc., 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Aventiv Research Inc., 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".